Skip to main content
Journal of Genetic Engineering and Biotechnology

Table 2 Detail of identified four drug candidates from the FDA library against RfaJ

From: Pangenome diversification and resistance gene characterization in Salmonella Typhi prioritized RfaJ as a significant therapeutic marker

Back to article page